Loading... Please wait...

Aldeyra Therapeutics, Inc. (ALDX) Competitors

Currency in USD Disclaimer
$3.20 -$0.05 (-1.54%)
$3.15
$3.3
$1.42
$8.38
Symbol Company Share Price Market Cap P/E Ratio Employee Count revenue rating
Ardelyx, Inc. $5.32 $1.51 B -23.04 267 $124.46 M
BioLineRx Ltd. $0.53 $55.34 M -0.87 79 $4.80 M
Blueprint Medicines Corporation $109.03 $6.47 B -21.48 645 $249.38 M
Cullinan Oncology, Inc. $16.78 $1.29 B -7.16 85 $0
Day One Biopharmaceuticals, Inc. $13.50 $1.12 B -5.11 174 $0
89bio, Inc. $7.48 $796.91 M -4.05 70 $0
Eton Pharmaceuticals, Inc. $3.29 $92.74 M 120.33 30 $31.64 M
Structure Therapeutics Inc. $37.45 $2.47 B -23.59 111 $0
HOOKIPA Pharma Inc. $0.58 $79.07 M -1.71 151 $20.13 M
ImmunityBio, Inc. $6.28 $4.22 B -5.65 628 $622,000
Inozyme Pharma, Inc. $4.49 $286.39 M -3.43 59 $0
LianBio $0.32 $34.47 M -0.39 163 $0
Lexicon Pharmaceuticals, Inc. $1.66 $632.61 M -2.11 285 $1.20 M
Lyra Therapeutics, Inc. $0.28 $19.53 M -0.27 109 $1.56 M
Seres Therapeutics, Inc. $0.70 $92.99 M -1.04 233 $126.33 M
Phathom Pharmaceuticals, Inc. $10.25 $620.47 M -2.38 452 $682,000
Tarsus Pharmaceuticals, Inc. $28.93 $1.22 B -6.78 244 $17.45 M
Terns Pharmaceuticals, Inc. $6.86 $462.44 M -5.67 66 $0
Travere Therapeutics, Inc. $7.94 $542.80 M -1.32 380 $145.24 M
Viridian Therapeutics, Inc. $12.25 $776.72 M -2.71 94 $314,000
X4 Pharmaceuticals, Inc. $0.56 $169.62 M -1.51 116 $0
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Log In


or

Continue with Google Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.